Journal article
TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent/metastatic head and neck squamous cell carcinoma.
- Guigay, Joel Centre Antoine-Lacassagne, Nice, France
- Keilholz, Ulrich Dpt.for Hemato-Oncology, Comprehensive Cancer Center, Charité University Medicine Berlin, Berlin, Germany
- Mesia, Ricard Institut Catala d'Oncologia, Barcelona, Spain
- Vintonenko, Nadejda GORTEC, Tours, France
- Bourhis, Jean CHUV, Lausanne, Switzerland
- Auperin, Anne Institut Gustave Roussy, Villejuif, France
Published in:
- Journal of Clinical Oncology. - American Society of Clinical Oncology (ASCO). - 2015, vol. 33, no. 15_suppl, p. TPS6087-TPS6087
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1200/jco.2015.33.15_suppl.tps6087
- ISSN 0732-183X
- Persistent URL
- https://folia.unifr.ch/global/documents/161675
Statistics
Document views: 18
File downloads: